Figure 6.
Kaplan–Meier analysis of event‐free survival (combined end point of death, urgent transplantation, or implantation of a ventricular assist device) according to (A) quartiles of fasting plasma glucose (FPG; in mmol·L−1 and mg·dL−1) and (B) combination of FPG above or below median and fasting glucagon above or below median. Number of participants at risk in each group is shown below the graphs.